Compare SGC & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGC | ORMP |
|---|---|---|
| Founded | 1920 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 192.8M | 170.3M |
| IPO Year | 1994 | 2010 |
| Metric | SGC | ORMP |
|---|---|---|
| Price | $12.04 | $4.10 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | 34.5K | ★ 175.4K |
| Earning Date | 05-04-2026 | 05-14-2026 |
| Dividend Yield | 4.93% | ★ 6.51% |
| EPS Growth | N/A | ★ 412.50 |
| EPS | 0.06 | ★ 0.91 |
| Revenue | ★ $566,184,000.00 | $2,000,000.00 |
| Revenue This Year | $3.23 | N/A |
| Revenue Next Year | $3.82 | N/A |
| P/E Ratio | $204.17 | ★ $4.53 |
| Revenue Growth | 0.09 | ★ 49.25 |
| 52 Week Low | $8.30 | $1.98 |
| 52 Week High | $14.59 | $5.19 |
| Indicator | SGC | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 39.47 | 46.72 |
| Support Level | $11.21 | $3.90 |
| Resistance Level | $12.35 | $4.22 |
| Average True Range (ATR) | 0.52 | 0.17 |
| MACD | -0.11 | -0.01 |
| Stochastic Oscillator | 0.00 | 33.80 |
Superior Group Of Companies Inc designs apparel products. The company operates through three segments: i) The Branded Products segment, under the brands BAMKO and HPI, produces and sells customized merchandising solutions, promotional products, and branded uniform programs. ii) The Healthcare Apparel segment, under the brands Wink and Fashion Seal Healthcare, manufactures and sells healthcare apparel including scrubs, lab coats, protective apparel, and patient garments. iii) The Contact Centers segment, through The Office Gurus entities, provides outsourced, nearshore, and onshore business process outsourcing (BPO), contact center, and call-center support services to customers in North America. The majority of the company's revenue is derived from the Branded Products segment.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.